Stay updated on PDR001/MBG453 w/ Decitabine in AML Clinical Trial

Sign up to get notified when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Study page content appears unchanged; the core sections such as Brief Summary, Detailed Description, Eligibility Criteria, Design, and Locations remain as published.
    Difference
    0.4%
    Check dated 2025-11-03T12:32:23.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    29 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T16:43:24.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T10:07:42.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page has been updated to revision v3.0.2 from v3.0.1, indicating a minor update with no substantive changes to core content, pricing, or availability. The 'Back to Top' link was removed, but this does not affect the main content.
    Difference
    0.2%
    Check dated 2025-09-14T00:19:41.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-06T21:12:14.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The webpage has been updated to include new resources related to myeloid leukemia and other blood disorders, as well as specific medications like decitabine and azacitidine. Additionally, the facility name and location details have been revised, while some previous resources and topics have been removed.
    Difference
    7%
    Check dated 2025-08-30T15:36:18.000Z thumbnail image

Stay in the know with updates to PDR001/MBG453 w/ Decitabine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.